Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (106)	3/29/1999 9:02:00 AM
From: LLCF	Read Replies (2) \| Respond to of 52153

Economist comments on biotech valuations: Message 8566999 DAK

To: LLCF who wrote (106)	3/31/1999 9:41:00 AM
From: Biomaven	Read Replies (3) \| Respond to of 52153

David, Your PCYC price slipped a decimal - in the wrong direction, what's more. <G> On a different topic, the cancer stocks are doing OK, with maybe an ENMD-bubble developing in SUGN. Here's a graph of the last 100 days in some of them that I follow: techstocks.com I currently own smallish amounts of IMCL and SUGN, and bigger amounts of MOGN and SUPG. Don't know if we'll get any bounce out of AACR - curing meece just doesn't have the same effect it used to in the old days <G>. If SUGN goes wild I'll sell it. Don't know why IMCL has been so strong recently. ONXX is looking cheap, but that's no recommendation these days <G>. Peter